Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Dyne Therapeutics Inc (NASDAQ: DYN) closed at $43.64 up 1.32% from its previous closing price of $43.07. In other words, the price has increased by $1.32 from its previous closing price. On the day, 0.96 million shares were traded. DYN stock price reached its highest trading level at $44.24 during the session, while it also had its lowest trading level at $41.9.
Ratios:
For a deeper understanding of Dyne Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 26.63 and its Current Ratio is at 26.63. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Chardan Capital Markets on May 21, 2024, Reiterated its Buy rating but revised its target price to $42 from $31 previously.
On April 30, 2024, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $40.
On February 20, 2024, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $36.H.C. Wainwright initiated its Buy rating on February 20, 2024, with a $36 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 09 ’24 when Kersten Dirk sold 92,164 shares for $42.96 per share. The transaction valued at 3,959,145 led to the insider holds 6,232,959 shares of the business.
Forbion Capital Fund IV Cooper bought 1,025,000 shares of DYN for $43,706,000 on Aug 08 ’24. On Aug 08 ’24, another insider, Kersten Dirk, who serves as the Director of the company, sold 91,670 shares for $42.74 each. As a result, the insider received 3,917,946 and left with 6,325,123 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 4381499392 and an Enterprise Value of 3616094720.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $45.46, while it has fallen to a 52-week low of $6.40. The 50-Day Moving Average of the stock is 15.43%, while the 200-Day Moving Average is calculated to be 77.44%.
Shares Statistics:
For the past three months, DYN has traded an average of 1.28M shares per day and 1021590 over the past ten days. A total of 99.46M shares are outstanding, with a floating share count of 69.73M. Insiders hold about 29.89% of the company’s shares, while institutions hold 68.12% stake in the company. Shares short for DYN as of 1722384000 were 9881196 with a Short Ratio of 7.72, compared to 1719532800 on 9076068. Therefore, it implies a Short% of Shares Outstanding of 9881196 and a Short% of Float of 11.85.
